PhytoHealth Corporation (TPE:4108)
Taiwan · Delayed Price · Currency is TWD 11.15
-0.25 (-2.19%)
Jul 30, 2026, 1:30 PM CST
PhytoHealth Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 138.56 | 134.58 | 153.56 | 162.49 | 135.47 | 168.94 |
Revenue Growth | -8.55% | -12.36% | -5.49% | 19.95% | -19.81% | 84.01% |
Gross Profit Gross Profit Growth | 43.66 | 41.29 | 64.01 | 67.64 | 57.03 | 78.31 |
Operating Income Operating Income Growth | -174.2 | -174.58 | -160.18 | -121.68 | -156.66 | -132.11 |
Net Income Net Income Growth | -59.13 | -58.2 | -73.5 | -47.12 | -79.41 | -77.72 |
Earnings Per Share EPS Growth | -0.30 | -0.29 | -0.37 | -0.24 | -0.40 | -0.40 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medicines and Health Food Medicines and Health Food Growth | 108.51 | 104.14 | 100.46 | 97.23 | 73.84 | 83.15 |
Precision Medical Devices Precision Medical Devices Growth | 20 | 21.31 | 41.4 | 52.9 | 51.05 | 52.13 |
Medical Diagnosis Medical Diagnosis Growth | 10.05 | 9.13 | 11.7 | 12.36 | 10.58 | 33.66 |
Adjustment and Elimination Adjustment and Elimination Growth | - | - | -0 | - | - | - |
Total Total Growth | 138.56 | 134.58 | 153.56 | 162.49 | 135.47 | 168.94 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 997.42 | 1,065 | 1,076 | 1,266 | 1,361 | 1,415 |
Total Debt Total Debt Growth | 23.96 | 15.73 | 18.34 | 28 | 30 | 30.87 |
Net Cash (Debt) Net Cash Growth | 973.47 | 1,049 | 1,058 | 1,238 | 1,331 | 1,384 |
Net Cash Growth | -23.87% | -0.84% | -14.56% | -6.96% | -3.84% | 86.57% |
Net Cash Per Share Net Cash Per Share Growth | 4.90 | 5.28 | 5.33 | 6.23 | 6.70 | 7.07 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -27.42 | -39.72 | -50.13 | -54.77 | -59.95 | -68.24 |
Capital Expenditures CapEx Growth | -5.18 | -5.54 | -4.72 | -4.91 | -1.61 | -13.22 |
Free Cash Flow Free Cash Flow Growth | -32.59 | -45.26 | -54.85 | -59.68 | -61.55 | -81.46 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.51% | 30.68% | 41.68% | 41.63% | 42.10% | 46.36% |
Operating Margin | -125.72% | -129.73% | -104.31% | -74.88% | -115.65% | -78.20% |
Pretax Margin | -78.47% | -81.82% | -70.68% | -45.63% | -84.69% | -56.54% |
Profit Margin | -42.68% | -43.25% | -47.86% | -29.00% | -58.62% | -46.00% |
FCF Margin | -23.52% | -33.63% | -35.72% | -36.73% | -45.44% | -48.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 16.34 | 19.92 | 21.73 | 26.53 | 28.00 | 27.39 |